Drug resistance to standard treatments is common in metastatic cancer: some reasons for this include tumor heterogeneity where cancer Read More
Cancer is on the rise worldwide: according to the World Health Organization, there will be over 35 million Read More
Radiation doses from computed tomography (CT) scans on patients are variable across patients and hospitals; those radiation doses Read More
Vator · Manny Krakaris, CEO of Augmedix, on the VatorNews podcast Steven Loeb and Bambi Francisco Roizen speak Read More
Swiss pharmaceutical company Galderma, which specializes in dermatological treatments and skin care products, was formed in 1981 by L’Oréal and Nestlé Read More
Cell engineering is the process of adding, deleting, or modifying genetic sequences in living cells, including altering cell Read More
Immune checkpoint blockade (ICB) is a treatment for cancer that involves the use of drugs, called immune checkpoint inhibitors Read More
Flagship Pioneering is a biotechnology company that creates and funds bioplatform companies; since its founded in 2000, it Read More
As we’ve previously written about, edtech is surging in the Middle East and North Africa (MENA) region: funding for Read More
Vator · Lyle Berkowitz, CEO of KeyCare, on the VatorNews podcast Steven Loeb speaks with Lyle Berkowitz, MD, Read More
Third Arc Bio is a company that says its on mission to deliver transformational therapies for solid tumors and inflammatory Read More
Artificial intelligence is touching literally every industry right now, from healthcare to logistics to eductation: globally, the AI Read More
The Middle East and North Africa (MENA) region, like the rest of the world, saw a major increase Read More
India spent just 3.28% of its GDP on healthcare in 2021, one of the lowest in the world; Japan, for Read More
While several US-based VC firms are increasingly looking at the MENA region for companies to invest in, they aren’t the Read More
